Peninsula & South Eastern Haematology & Oncology Group

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors	Advanced Solid Tumors	Recruiting	Phase 1 / Phase 2	2026-05-06		NCT06819735
A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors	Disease Attributes, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasm	Recruiting	Phase 1	2025-06-08		NCT06063681

Clinical trials